Neurology Archives | Page 205 of 293

Neurology

FDA Accepts sNDA for Higher Dose Nusinersen, Tofersen Demonstrates Real-World Efficacy, Nipocalimab Gains Priority Review

Neurology News Network. for the week ending January 25, 2025. : Source: Neurology Read More

January 25, 2025

Neurology

OnabotulinumtoxinA Appears to be Safe and Effective in Pediatric Chronic Migraine, With More Controlled Studies Needed

OnabotulinumtoxinA injections are safe and well-tolerated in children and adolescents, with no patients reporting severe…

January 25, 2025

Neurology

NeurologyLive® Friday 5 — January 24, 2024

Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending January 24,…

January 24, 2025

Neurology

Feasibility and Scalability of Amprion’s Assay for Synucleinopathy Diagnosis: Russ Lebovitz, MD, PhD

The chief executive officer and cofounder of Amprion discussed the integration process of a novel…

January 24, 2025

Neurology

Survey Highlights Patients’ Need for Support in Adapting to Life in Narcolepsy or Idiopathic Hypersomnia

In a recent survey, key factors associated with perceived support included knowing someone who had…

January 24, 2025

Neurology

Insights From the Child Neurology Foundation: Enhancing Pediatric Epilepsy Care Through Holistic Collaboration

Jessica Nickrand, PhD, and Allyson Eyermann from the Child Neurology Foundation emphasized the importance of…

January 24, 2025

Neurology

Episode 133: Clinical Guidance on Neuromodulation for Lennox-Gastaut Syndrome

Mind Moments®, a podcast from NeurologyLive®, brings you an exclusive interview with Depobam Samanta, MD,…

January 24, 2025

Neurology

FDA Accepts sNDA for Higher Dosing Regimen of Nusinersen for Spinal Muscular Atrophy

In the phase 2/3 DEVOTE study, a higher dose of nusinersen met its primary end…

January 24, 2025

Neurology

Personalizing Neuromodulation and Tailoring Approaches for Lennox-Gastaut Syndrome: Depobam Samanta, MD, MS, FAAP, FAES

The medical director of the Arkansas Children’s Comprehensive Epilepsy Program provided commentary on patient selection…

January 24, 2025

Neurology

Comparison of CGRP-Targeting Treatments and OntabotulinumtoxinA Shows No Increased Cardiovascular Disease Risk

Post Content: Source: Neurology Read More

January 23, 2025

Neurology

FDA Accepts sNDA for Higher Dose Nusinersen, Tofersen Demonstrates Real-World Efficacy, Nipocalimab Gains Priority Review

OnabotulinumtoxinA Appears to be Safe and Effective in Pediatric Chronic Migraine, With More Controlled Studies Needed

NeurologyLive® Friday 5 — January 24, 2024

Feasibility and Scalability of Amprion’s Assay for Synucleinopathy Diagnosis: Russ Lebovitz, MD, PhD

Survey Highlights Patients’ Need for Support in Adapting to Life in Narcolepsy or Idiopathic Hypersomnia

Insights From the Child Neurology Foundation: Enhancing Pediatric Epilepsy Care Through Holistic Collaboration

Episode 133: Clinical Guidance on Neuromodulation for Lennox-Gastaut Syndrome

FDA Accepts sNDA for Higher Dosing Regimen of Nusinersen for Spinal Muscular Atrophy

Personalizing Neuromodulation and Tailoring Approaches for Lennox-Gastaut Syndrome: Depobam Samanta, MD, MS, FAAP, FAES

Comparison of CGRP-Targeting Treatments and OntabotulinumtoxinA Shows No Increased Cardiovascular Disease Risk

Recent Posts

Trending Posts

New in Neurology

Categories

Neurology

Recent Posts

Trending Posts

Tags

New in Neurology

Categories